---
title: "Poly Medicure Ltd (POLYMED) — Share Price, Financials & Analysis"
symbol: "POLYMED"
company: "Poly Medicure Ltd"
canonical: "https://tapetide.com/stocks/POLYMED"
isin: "INE205C01021"
nse_symbol: "POLYMED"
bse_code: "531768"
sector: "Healthcare"
industry: "Medical Equipment"
market_cap_cr: 17424.71
generated_at: "2026-09-13T19:15:41.401Z"
---

# Poly Medicure Ltd (POLYMED)

Canonical page: https://tapetide.com/stocks/POLYMED

## Company

- **NSE Symbol:** POLYMED
- **BSE Code:** 531768
- **ISIN:** INE205C01021
- **Sector:** Healthcare
- **Industry:** Medical Equipment
- **Macro Sector:** Healthcare
- **Stock Type:** EQUITY
- **Listed Since:** 2011-12-07
- **CEO:** Mr. Himanshu Baid
- **Employees:** 3082
- **Face Value:** ₹5
- **F&O Eligible:** No
- **Website:** polymedicure.com

## About

Poly Medicure Limited is an India-based manufacturer and exporter of medical devices. The Company exports plastic medical disposables/surgical devices.[1]

## Latest Price

- **Price:** ₹1738.5
- **Change:** -9.2 (-0.53%)
- **Open:** ₹1740.1
- **Day High:** ₹1741.2
- **Day Low:** ₹1709.7
- **Previous Close:** ₹1747.7
- **Volume:** 69913
- **As Of:** 2026-09-11T10:22:08+00:00

## Key Fundamentals

Observed at 2026-09-11T04:43:39.391722Z.

- **Market Cap:** ₹17424.71 Cr
- **Classification:** Smallcap
- **P/E (reported):** 56.6
- **P/E (TTM):** 55.92
- **EPS (TTM):** ₹31.09
- **EPS (reported):** ₹28.09
- **Book Value:** ₹306.45
- **Price to Book:** 5.7
- **Dividend Yield:** 0.2%
- **ROE:** 10.18%
- **ROCE:** 13.33%
- **Debt to Equity:** 0.11
- **Revenue (yearly):** ₹1995.3 Cr
- **Net Income:** ₹320.7 Cr
- **EBITDA:** ₹562.4 Cr
- **52-Week High:** ₹2107.8
- **52-Week Low:** ₹1182
- **RSI (14):** 52.3

## Tapetide Score

- **Score:** 46 / 100
- **Score date:** 2026-09-04
- **Archetype:** Weak and Under Pressure
- **What it means:** Weak financials are the defining feature, and neither the valuation nor the trend reading is strong enough to offset them. Worth reading the risk flags and recent filings closely before anything else.
- **Pillar profile:** Quality: Weak · Valuation: Expensive · Momentum: Flat
- **Percentile:** 31.9 (of 4473 scored stocks)
- **Confidence:** 100%
- **Data coverage:** 100%

| Pillar | Score | Weight |
| --- | --- | --- |
| financial health | 74.54 | 9% |
| growth | 53.79 | 9% |
| momentum | 50.07 | 12% |
| ownership | 52.41 | 24% |
| quality | 37.62 | 22% |
| valuation | 28.58 | 24% |

The Tapetide Score is decision-support only, not investment advice.

## Key Insights

### Weaknesses

- Company has a low return on equity of 12.6% over last 3 years.
- Debtor days have increased from 83.9 to 103 days.

## Growth Rates

| Metric | QoQ | 1Y | 3Y | 5Y |
| --- | --- | --- | --- | --- |
| cash flow growth | — | 5.72% | -7.41% | 99.54% |
| ebitda margin growth | 23.25% | -8.59% | -2.89% | 7.92% |
| net income growth | 31.23% | -5.29% | 15% | 14% |
| revenue growth | 1.14% | 13.43% | 19% | 19% |
| roce | 35.12% | -19.02% | -43.49% | 17.98% |
| roe | 31.1% | -16.83% | 13.33% | -24.42% |

## Financial Statements

### Quarterly Results

All figures in ₹ crore unless the row name says otherwise.

| Item | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Sales | 337 | 340 | 378 | 385 | 420 | 424 | 441 | 403 | 444 | 494 | 535 | 525 |
| Expenses | 253 | 249 | 282 | 281 | 305 | 310 | 321 | 298 | 329 | 382 | 424 | 400 |
| Operating Profit | 84 | 90 | 96 | 104 | 115 | 114 | 119 | 106 | 115 | 111 | 110 | 125 |
| OPM % | 25 | 27 | 26 | 27 | 27 | 27 | 27 | 26 | 26 | 23 | 21 | 24 |
| Other Income | 15 | 17 | 15 | 17 | 27 | 24 | 27 | 43 | 35 | 21 | 19 | 35 |
| Interest | 2 | 3 | 3 | 3 | 3 | 3 | 2 | 3 | 3 | 6 | 6 | 6 |
| Depreciation | 16 | 16 | 16 | 20 | 21 | 21 | 21 | 23 | 25 | 29 | 38 | 36 |
| Profit before tax | 81 | 88 | 92 | 98 | 118 | 113 | 123 | 123 | 122 | 98 | 85 | 117 |
| Tax % | 23 | 26 | 26 | 25 | 26 | 25 | 25 | 24 | 25 | 27 | 24 | 27 |
| Net Profit | 62 | 65 | 68 | 74 | 87 | 85 | 92 | 93 | 92 | 71 | 65 | 85 |
| EPS in Rs | 6.48 | 6.78 | 7.12 | 7.71 | 8.63 | 8.41 | 9.06 | 9.19 | 9.06 | 7 | 6.54 | 8.49 |

### Profit & Loss

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Sales | 519 | 610 | 687 | 785 | 922 | 1115 | 1375 | 1669 | 1875 | 1997 |
| Expenses | 397 | 479 | 520 | 569 | 707 | 847 | 1014 | 1213 | 1429 | 1536 |
| Operating Profit | 122 | 131 | 166 | 216 | 215 | 267 | 361 | 456 | 446 | 461 |
| OPM % | 23 | 22 | 24 | 28 | 23 | 24 | 26 | 27 | 24 | 23 |
| Other Income | 16 | 20 | 21 | 22 | 40 | 38 | 60 | 94 | 119 | 110 |
| Interest | 12 | 14 | 20 | 11 | 6 | 11 | 14 | 14 | 21 | 22 |
| Depreciation | 29 | 37 | 41 | 48 | 54 | 57 | 63 | 83 | 116 | 128 |
| Profit before tax | 97 | 100 | 126 | 180 | 195 | 237 | 344 | 453 | 427 | 422 |
| Tax % | 27 | 35 | 24 | 25 | 25 | 25 | 25 | 25 | 25 | — |
| Net Profit | 71 | 65 | 96 | 136 | 147 | 179 | 258 | 339 | 321 | 313 |
| EPS in Rs | 8 | 7.41 | 10.86 | 14.17 | 15.28 | 18.69 | 26.91 | 33.41 | 31.78 | 31.09 |
| Dividend Payout % | 25 | 27 | 18 | 18 | 16 | 16 | 11 | 10 | 11 | — |

### Balance Sheet

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Equity Capital | 44 | 44 | 44 | 44 | 48 | 48 | 48 | 48 | 51 | 51 |
| Reserves | 227 | 294 | 337 | 391 | 918 | 1040 | 1194 | 1422 | 2715 | 3055 |
| Borrowings | 101 | 133 | 161 | 207 | 137 | 127 | 149 | 174 | 180 | 354 |
| Other Liabilities | 85 | 94 | 112 | 126 | 121 | 163 | 187 | 215 | 246 | 401 |
| Total Liabilities | 457 | 565 | 654 | 767 | 1224 | 1377 | 1577 | 1859 | 3192 | 3861 |
| Fixed Assets | 207 | 265 | 306 | 363 | 426 | 488 | 635 | 867 | 1084 | 1694 |
| CWIP | 20 | 18 | 19 | 25 | 21 | 43 | 78 | 76 | 101 | 99 |
| Investments | 3 | 17 | 8 | 25 | 354 | 346 | 126 | 167 | 1076 | 755 |
| Other Assets | 227 | 264 | 321 | 354 | 422 | 499 | 738 | 748 | 930 | 1313 |
| Total Assets | 457 | 565 | 654 | 767 | 1224 | 1377 | 1577 | 1859 | 3192 | 3861 |

### Cash Flow

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash from Operating Activity | 56 | 75 | 106 | 131 | 119 | 123 | 191 | 266 | 233 | 246 |
| Cash from Investing Activity | -56 | -88 | -101 | -109 | -436 | -85 | -179 | -241 | -1187 | -224 |
| Cash from Financing Activity | 0 | 16 | -5 | -21 | 317 | -35 | -13 | -20 | 951 | 20 |
| Net Cash Flow | 0 | 3 | 1 | 1 | 0 | 3 | -1 | 5 | -3 | 43 |
| Free Cash Flow | 0 | -7 | 31 | 25 | 24 | -31 | -48 | -9 | -97 | -59 |
| CFO/OP | 79 | 80 | 102 | 100 | 75 | 80 | 93 | 94 | 71 | 78 |

### Ratios

| Item | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Debtor Days | 77 | 79 | 77 | 68 | 72 | 82 | 77 | 72 | 76 | 103 |
| Inventory Days | 194 | 161 | 186 | 241 | 217 | 218 | 237 | 205 | 233 | 323 |
| Days Payable | 131 | 96 | 123 | 142 | 111 | 115 | 105 | 89 | 70 | 91 |
| Cash Conversion Cycle | 140 | 144 | 139 | 166 | 179 | 185 | 209 | 188 | 239 | 335 |
| Working Capital Days | 55 | 71 | 56 | 42 | 74 | 81 | 69 | 54 | 75 | 105 |
| ROCE % | 24 | 26 | 22 | 25 | 22 | 17 | 18 | 24 | 18 | 12 |

## Shareholding Pattern

### Quarterly

| Category | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Promoters | 53.16% | 53.16% | 53.15% | 66.03% | 62.56% | 62.44% | 62.44% | 62.44% | 62.42% | 62.42% | 62.42% | 62.42% |
| FIIs | 14.49% | 14.1% | 12.38% | 9.91% | 11.87% | 12.33% | 11.46% | 11.41% | 9.77% | 9.4% | 5.91% | 5.57% |
| DIIs | 5.15% | 5.28% | 7.22% | 9.35% | 12.33% | 11.66% | 11.96% | 11.72% | 13.54% | 13.84% | 15.59% | 16.08% |
| Government | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| Public | 11.35% | 11.38% | 11.34% | 11.37% | 10.14% | 10.55% | 11.08% | 11.37% | 11.25% | 11.3% | 12.61% | 12.18% |
| Others | 15.85% | 16.07% | 15.92% | 3.36% | 3.1% | 3.03% | 3.07% | 3.07% | 3.02% | 3.04% | 3.47% | 3.76% |
| No. of Shareholders | 34649 | 36053 | 36712 | 36852 | 38352 | 60686 | 65583 | 71142 | 64400 | 67750 | 73414 | 73643 |

## Technical Indicators

Derived from daily closing prices and recomputed each trading session; values move with the market.

- **Overall Signal:** Buy
- **Buy / Neutral / Sell:** 9 / 7 / 3

### Moving Averages — summary: **Strong Buy**

| Indicator | Value | Signal |
| --- | --- | --- |
| SMA (10) | 1741.24 | Sell |
| EMA (10) | 1736.67 | Buy |
| SMA (20) | 1740.79 | Sell |
| EMA (20) | 1737.63 | Buy |
| SMA (50) | 1719.34 | Buy |
| EMA (50) | 1705.59 | Buy |
| SMA (100) | 1624.44 | Buy |
| EMA (100) | 1655.86 | Buy |
| SMA (200) | 1587.64 | Buy |
| EMA (200) | 1682.2 | Buy |

### Oscillators — summary: **Neutral**

| Indicator | Value | Signal |
| --- | --- | --- |
| RSI (14) | 50.82 | Neutral |
| MACD (12,26,9) | 3.08 | Sell |
| Stochastic (14,3,3) | 31.22 | Neutral |
| ADX (14) | 15.86 | Neutral |
| Williams %R (14) | -67.78 | Neutral |
| ATR (14) | 60.42 | High Volatility |
| ROC (12) | 1.6 | Buy |
| Stoch RSI (14) | 45.95 | Neutral |
| UO (7,14,28) | 40.93 | Neutral |

## Analyst Ratings

| Recommendation | Analysts | Share |
| --- | --- | --- |
| Buy | 3 | 60% |
| Hold | 2 | 40% |
| Sell | 0 | 0% |

Based on 5 analyst ratings, observed at 2026-09-11T04:43:41.857700+00:00.

## Filings & Documents

### Exchange Filings & Announcements

| Date | Document |
| --- | --- |
| 2026-09-07 | [Shareholder Meeting / Postal Ballot-Scrutinizers Report](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=9fa14bf5-4876-40c0-beb3-19b74686f838.pdf) |
| 2026-09-05 | [Shareholder Meeting / Postal Ballot-Outcome of AGM](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=469a4c61-b789-4cc5-ac98-38a4ec8fc3ef.pdf) |
| 2026-09-02 | [Intimation For The Schedule Of Investors/Analysts Call/Meet.](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=850d7a17-cfae-4187-857d-f7446b4ed10f.pdf) |
| 2026-08-25 | [Intimation On Rescheduling Of Investor/Analyst Meet.](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=4f07f2ff-08d2-46eb-863e-0f4d68c473a5.pdf) |
| 2026-08-22 | [Intimation For The Schedule Of Investors/Analysts Call/Meet.](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=fb027a67-71d0-4c23-af14-4607bede883e.pdf) |
| 2026-08-20 | [Investors Call Scheduled To Be Held On 20 August 2026 Is Cancelled - Updates On Call](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=13969d1a-7402-449e-919b-8b807990fd7e.pdf) |
| 2026-08-17 | [Intimation For The Schedule Of Investors/Analysts Call/Meet.](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=8d6756ec-457b-4ca8-8972-80b85ac79974.pdf) |
| 2026-08-15 | [Announcement under Regulation 30 (LODR)-Newspaper Publication](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=501973eb-edba-4a58-913a-5b2cf891e7d7.pdf) |
| 2026-08-14 | [31ST Annual General Meeting To Be Held On September 05Th 2026](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=d738814a-1e7f-4588-bd10-1dfedd0709c6.pdf) |
| 2026-08-14 | [Business Responsibility and Sustainability Reporting (BRSR)](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=d4503366-0f9e-4c2a-86d8-acfc12405d34.pdf) |

### Results & Financial Statements

| Date | Document |
| --- | --- |
| 2026-08-07 | [Standalone & Consolidated Unaudited Financial Results For The Quarter Ended 30Th June 2026](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=7ac5a576-893f-4232-aedd-0dcc40d17a47.pdf) |
| 2026-05-25 | [Audited Financial Results (Standalone & Consolidated) For The Quarter And Financial Year Ended 31St March 2026](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=794fe3eb-6dbc-4775-b303-7941be952ea8.pdf) |
| 2026-05-25 | [Declaration Of Unmodified Opinion On The Audited Financial Results(Standalone & Consolidated) For The Quarter And Year Ended For The 31St March 2026](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=17cdfe62-6058-469c-9d3b-d634d14adf15.pdf) |
| 2026-02-05 | [Unaudited Financial Results (Standalone & Consolidated) For The Third Quarter And Nine Months Ended On 31St December 2025.](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=2b673af4-7e9d-4c1e-bbd8-361b1758baa3.pdf) |
| 2025-11-08 | [Declaration Of Unaudited Financial Results For The Second Quarter And Half Year Ended For 30Th September 2025.](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=71e2be97-fcd7-4aa5-92b3-e7fe5402507c.pdf) |
| 2025-08-08 | [Unaudited Standalone & Consolidated Financial Results For The Quarter Ended 30Th June 2025 Declared As Outcome Of The Board Meeting Held On Today I.E. 08Th August 2025](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=31c24140-efd4-48e9-8cb0-975d233dfbc6.pdf) |
| 2025-05-06 | [Audited Standalone & Consolidated Financial Results For The Quarter And Year Ended 31.03.2025](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=bbfefef6-1a54-4fa8-a854-38ac3005b388.pdf) |
| 2025-02-03 | [Unaudited Financial Results (Standalone & Consolidated) For The Third Quarter And Nine Months Ended On 31St December 2024](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=8121f3e4-6ed0-494c-9018-a1a983a752c3.pdf) |
| 2024-10-28 | [Financial Results For The Quarter And Half Year Ended On 30Th September, 2024.](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=62a207d5-1af9-4b4f-84ed-e320fb735878.pdf) |
| 2024-07-22 | [Unaudited Financial Results (Standalone & Consolidated) For The Quarter Ended 30Th June, 2024 In Compliance Of Regulation 30 And 33 Of SEBI (LODR) Regulations, 2015](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=4885d662-9c20-4089-9d68-6724a7ba3be1.pdf) |

### Investor Presentations

| Date | Document |
| --- | --- |
| 2026-08-07 | [Announcement under Regulation 30 (LODR)-Investor Presentation](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=3d2b03da-7262-404e-99d3-e81859b263b0.pdf) |
| 2026-05-25 | [Announcement under Regulation 30 (LODR)-Investor Presentation](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=3f7ed3cc-b704-497d-b30f-800cd36a3366.pdf) |
| 2026-05-25 | [Announcement under Regulation 30 (LODR)-Investor Presentation](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=09463756-ab9c-438e-8924-2d5ebaa76fce.pdf) |
| 2026-03-07 | [Announcement under Regulation 30 (LODR)-Investor Presentation](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=14ad8123-66e3-409b-a1ac-bb082f8ce394.pdf) |
| 2026-02-05 | [Announcement under Regulation 30 (LODR)-Investor Presentation](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=aaef19c5-4a0c-4fc8-915e-02ab392a3659.pdf) |
| 2025-11-08 | [Announcement under Regulation 30 (LODR)-Investor Presentation](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=3d324073-0f89-440f-9b06-18ec3a20ceed.pdf) |
| 2025-09-25 | [Announcement under Regulation 30 (LODR)-Investor Presentation](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=9b04bb12-3eba-4efb-a8f1-8641ca78a36c.pdf) |
| 2025-09-24 | [Announcement under Regulation 30 (LODR)-Investor Presentation](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=9a078da1-18a5-4d79-ba36-db8f919904c2.pdf) |
| 2025-09-03 | [Announcement under Regulation 30 (LODR)-Investor Presentation](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=7e5a38b2-9453-4c50-9603-f4965c52ed39.pdf) |
| 2025-08-08 | [Announcement under Regulation 30 (LODR)-Investor Presentation](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=ae6ba797-6b97-44f1-96d9-972e10546943.pdf) |

### Earnings Call Transcripts

| Date | Document |
| --- | --- |
| 2026-05-29 | [Announcement under Regulation 30 (LODR)-Earnings Call Transcript](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=b7df1ec2-9755-4d34-a5dc-b26778961a06.pdf) |
| 2026-02-11 | [Announcement under Regulation 30 (LODR)-Earnings Call Transcript](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=de985b3e-7982-450c-a31e-b8981be570ce.pdf) |
| 2025-11-14 | [Announcement under Regulation 30 (LODR)-Earnings Call Transcript](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=d732241a-17d9-413d-b33d-0b82885f04b4.pdf) |
| 2025-08-14 | [Announcement under Regulation 30 (LODR)-Earnings Call Transcript](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=9cb43412-cd15-4b50-b5d6-9594c63349d9.pdf) |
| 2025-05-13 | [Announcement under Regulation 30 (LODR)-Earnings Call Transcript](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=e05528f4-536e-4cda-adec-707eae1fba60.pdf) |
| 2025-02-10 | [Announcement under Regulation 30 (LODR)-Earnings Call Transcript](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=3e1b327a-169a-429c-ada8-3f0d2cf341ba.pdf) |
| 2024-11-06 | [Announcement under Regulation 30 (LODR)-Earnings Call Transcript](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=505281ea-c025-4d53-8bf7-bd0ee743bb44.pdf) |
| 2024-07-31 | [Announcement under Regulation 30 (LODR)-Earnings Call Transcript](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=84d2d3bd-440f-4a26-adb9-7aca9f931642.pdf) |
| 2024-05-24 | [Announcement under Regulation 30 (LODR)-Earnings Call Transcript](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=c563081a-3d38-480a-8c5c-6568e767dafc.pdf) |
| 2024-02-09 | [Announcement under Regulation 30 (LODR)-Earnings Call Transcript](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=7558e17b-2866-44f4-8b06-f2632b5e0b1d.pdf) |

### Earnings Call Documents

| Date | Document |
| --- | --- |
| Sep 2025 | [Concall - Sep 2025](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=07d26651-7d36-4c6b-ba00-e755ceeb1ee0.pdf) |
| Sep 2025 | [Concall - Sep 2025](https://www.bseindia.com/xml-data/corpfiling/AttachHis/9cb43412-cd15-4b50-b5d6-9594c63349d9.pdf) |
| Sep 2025 | [Concall - Sep 2025](https://www.bseindia.com/xml-data/corpfiling/AttachHis/07d26651-7d36-4c6b-ba00-e755ceeb1ee0.pdf) |
| Oct 2025 | [Concall - Oct 2025](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=b8340ad9-4f2d-49f4-b5f6-c7de62556299.pdf) |
| Oct 2025 | [Concall - Oct 2025](https://www.bseindia.com/xml-data/corpfiling/AttachHis/b8340ad9-4f2d-49f4-b5f6-c7de62556299.pdf) |
| Nov 2025 | [Concall - Nov 2025](https://www.bseindia.com/xml-data/corpfiling/AttachHis/d732241a-17d9-413d-b33d-0b82885f04b4.pdf) |
| Nov 2024 | [Concall - Nov 2024](https://www.bseindia.com/xml-data/corpfiling/AttachHis/505281ea-c025-4d53-8bf7-bd0ee743bb44.pdf) |
| Nov 2023 | [Concall - Nov 2023](https://www.bseindia.com/xml-data/corpfiling/AttachHis/365d4d3f-24f5-41cb-9f34-cffd63004700.pdf) |
| May 2026 | [Concall - May 2026](https://www.bseindia.com/xml-data/corpfiling/AttachHis/b7df1ec2-9755-4d34-a5dc-b26778961a06.pdf) |
| May 2026 | [Concall - May 2026](https://www.bseindia.com/xml-data/corpfiling/AttachLive/b7df1ec2-9755-4d34-a5dc-b26778961a06.pdf) |

### Other Documents

| Date | Document |
| --- | --- |
| 7 Mar - One-on-one meetings with Quant Mutual Fund (9 Mar 2026) and Carnelian Capital (10 Mar 2026) in Mumbai. | [Poly Medicure Limited Has informed About Investors/Analysts Call/Meet On 09Th March, 2026 And 10Th March, 2026. 7 Mar - One-on-one meetings with Quant Mutual Fund (9 Mar 2026) and Carnelian Capital (10 Mar 2026) in Mumbai.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/4946a42e-c85b-4536-8893-a7768915920c.pdf) |
| 30 Apr - Polymed Brazil acquired 100% of MEDYNEO for R$180,000, gaining Brazilian medical device licenses. | [Announcement under Regulation 30 (LODR)-Acquisition 30 Apr - Polymed Brazil acquired 100% of MEDYNEO for R$180,000, gaining Brazilian medical device licenses.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/d5c701c9-06b9-4d20-bd6d-82d37f69a3c9.pdf) |
| 30 Apr - Polymed Brazil acquired 100% of MEDYNEO for R$180,000, gaining Brazilian medical device licenses. | [Announcement under Regulation 30 (LODR)-Acquisition 30 Apr - Polymed Brazil acquired 100% of MEDYNEO for R$180,000, gaining Brazilian medical device licenses.](https://www.bseindia.com/xml-data/corpfiling/AttachLive/d5c701c9-06b9-4d20-bd6d-82d37f69a3c9.pdf) |
| 3 Mar - Poly Medicure to attend Investec India Promoter & Founder Conference on Mar 9-10, 2026 in Mumbai (in-person). | [Intimation Of Analysts/Investors Meet To Be Held On 9Th And 10Th March, 2026 3 Mar - Poly Medicure to attend Investec India Promoter & Founder Conference on Mar 9-10, 2026 in Mumbai (in-person).](https://www.bseindia.com/xml-data/corpfiling/AttachHis/a833ec62-bea4-4fa4-9011-db1c3b177382.pdf) |
| 25 Mar - One-on-one virtual investor meeting with Front Wave Research LLP on 30 March 2026 at 03:30 PM. | [Poly Medicure Limited Has informed About Investors/Analysts Call Schedule On 30Th March, 2026 25 Mar - One-on-one virtual investor meeting with Front Wave Research LLP on 30 March 2026 at 03:30 PM.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/e8de226a-6ef3-4aef-bc2d-7fe98d9c19c9.pdf) |
| 2 Mar - Virtual one-on-one investor meeting with Grandeur Peak Funds on 06 March 2026 at 09:30 AM. | [Intimation Of Analysts/Investors Meet To Be Held On 6Th March, 2026 2 Mar - Virtual one-on-one investor meeting with Grandeur Peak Funds on 06 March 2026 at 09:30 AM.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/d70cd1f8-2f1c-40ab-8e60-233286536b9a.pdf) |
| 19 Mar - TCG meeting (20 Mar) cancelled; one-on-one virtual meetings with Avendus and Quantum on 24 Mar. | [Poly Medicure Limited Has informed About Investors/Analysts Call Schedule On 24Th March, 2026 And Cancellation Of Investors/Analysts Call Scheduled On 20Th March, 2026 19 Mar - TCG meeting (20 Mar) cancelled; one-on-one virtual meetings with Avendus and Quantum on 24 Mar.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/636bb3db-93f5-4fa8-8725-6f6573d5ed5d.pdf) |
| 17 Mar - One-on-one virtual investor meeting with TCG Asset Management on 20 March 2026 at 02:30 PM. | [Poly Medicure Limited Has informed About Investors/Analysts Call/Meet On 20Th March, 2026 17 Mar - One-on-one virtual investor meeting with TCG Asset Management on 20 March 2026 at 02:30 PM.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/d6975553-a514-49a4-9085-86de6a4c2d7f.pdf) |
| 15 Apr - Submitted Regulation 74(5) confirmation certificate for quarter ended 31 March 2026. | [Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 15 Apr - Submitted Regulation 74(5) confirmation certificate for quarter ended 31 March 2026.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/2a57dbae-7dc6-4b1a-9505-12f4f93f3ac5.pdf) |
| 12 Mar - One-on-one investor meeting with Avendus Spark on 19 March 2026 at 5:00 PM (virtual). | [Poly Medicure Limited Has informed About Investors/Analysts Call/Meet On 19Th March, 2026 12 Mar - One-on-one investor meeting with Avendus Spark on 19 March 2026 at 5:00 PM (virtual).](https://www.bseindia.com/xml-data/corpfiling/AttachHis/fa16f9b3-9835-4541-9943-cff46dde6995.pdf) |

### Earnings Call Recordings

| Date | Document |
| --- | --- |
| 2026-02-06 | [Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f2ad0053-342e-4e58-801e-98e32c788266.pdf) |
| 2025-11-10 | [Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=3090b290-5fcc-4b06-bd61-4949eea5d0a3.pdf) |
| 2025-09-25 | [Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=10b8500e-c0c7-4d30-914c-b99138f9e274.pdf) |
| 2025-09-04 | [Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=49d19e08-3ba1-4d2d-96a3-bfa679cb3f79.pdf) |
| 2025-08-08 | [Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f563b1e4-67ae-417c-bec2-36a742fb4e43.pdf) |
| 2025-05-07 | [Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=bc5db497-10c3-49b9-a330-3d002f002987.pdf) |
| 2024-10-29 | [Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=9a1c4376-41b9-46dc-957a-6cef1e2e7c48.pdf) |
| 2024-07-24 | [Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=9bd94e8e-1aa0-4912-b9ad-4ccbfd4f0038.pdf) |
| 2024-05-21 | [Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=c2a3f117-eeda-40e5-ad3c-f0ada772598e.pdf) |
| 2024-02-03 | [Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=37aab509-b292-471f-b339-8029f96ef5ae.pdf) |

### Annual Reports

| Date | Document |
| --- | --- |
| from bse | [Annual Report 2025 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/77291bf8-69b3-4603-8d57-622f1c03138a.pdf) |
| from bse | [Annual Report 2024 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/3df7e7b8-f51a-4484-a267-3bb23f169347.pdf) |
| from bse | [Annual Report 2023 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/83e61597-6316-44af-b63f-30aa77d2ebba.pdf) |

---

Provenance differs by section. Financial statements, shareholding and filings are as reported in company disclosures to NSE/BSE/SEBI. Price, volume and 52-week levels are exchange market data. Technical indicators are computed by Tapetide from daily closing prices. The Tapetide Score is Tapetide's own analysis. Analyst ratings are third-party estimates, not company statements. All figures are for research and information only and are not investment advice. Generated 2026-09-13T19:15:41.401Z.